The European Commission has granted marketing authorization for Eylea 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for ...

European Commission grants marketing approval for Eylea 8 mg to treat macular edema following RVO, including branch, central and hemiretinal vein occlusion: Berlin Monday, January ...

Three firms receive favourable recommendation from SEC on semaglutide formulations: Gireesh Babu, New Delhi Monday, January 19, 2026, 08:00 Hrs [IST] With the patent for Danish dr ...

Contract manufacturer introduces injection device featuring adjustable parameters and streamlined assembly process.

Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...

MGS, a provider of end-to-end healthcare solutions, has launched the A.i.r. Platform, a customizable auto-injector platform ...

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...

Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public to the recall of Mivacron ...

The National Agency for Food and Drug Administration and Control has alerted Nigerians to the recall of Mivacron and Nimbex injections over safety concerns.\u200e\u200e The agency, in a post on its X ...

Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...